The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
The role of the brain reward system in depression
Abstract
The goal of this review is to familiarize the reader about the potential involvement of the brain reward system (BRS) in symptoms of Major Depressive Disorder (MDD). The authors introduce a novel approach to study the pathophysiology of MDD that includes pharmacological probing of BRS pathways (e.g. d-amphetamine, hydromorphone) together with an elicited and measurable behavioral component (e.g. pleasant effects, increased energy, altered cognition). To this date, the major focus of MDD pathophysiology studies has been to characterize biological differences between healthy subjects and depressed patients such as alteration in the monoaminergic and endocrine systems. The relative importance of the various biological changes has not been elucidated, that is, linking these with specific behavioral manifestations in MDD have rarely been attempted. One core symptom of MDD is a decreased experience of pleasure or interest in previously enjoyed activities (i.e. anhedonia) such as work or hobbies, and is accompanied by decreased motivation or drive. The BRS consists of the neural pathways involved in eliciting rewarding experiences in animals and humans. The hypothesis is that altered BRS function may be an underlying brain mechanism of the loss of pleasure/interest experienced in MDD, and will be manifested through an altered response to a BRS probe. The authors have examined BRS function in MDD by introducing a pharmacological probe (i.e. d-amphetamine/d-amph). Amphetamine is defined as a probe due to its ability to release dopamine within major components of the BRS (i.e. the mesocorticolimbic dopamine system.) In addition to the objective pharmacological effects (e.g. altered heart rate), BRS probes like d-amph elicit reliable and measurable behavior, that is, the hedonic effects. A review of the neurobiology of MDD, the BRS, the rationale for implicating the BRS in depressive symptoms, and preliminary data, are presented in this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These systems play key roles in neurotransmission, brain maturation, cortical organisation and behaviours (including social behaviour and repetitive behaviour) [180,181,182,183,184].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [182]
In the citing paper
“Multiple lines of evidence suggest an involvement of dysregulated neurotransmitter systems (serotonergic, oxytocinergic and dopaminergic systems) in autism.”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [182]
Citations
Cites
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Olds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176
Ongur, D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.206 · Cited by 2,627
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
Bell, C. C. (1994) · JAMA · doi:10.1001/jama.1994.03520100096046 · Cited by 2,608
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,527
Research works printed but not linked: 7
- 1999, Guidelines for the Diagnosis and Pharmacological Treatment of Depression
- Cardenas, 2000, Dopaminergic activity in depressed smokers, Br. J. Clin. Pharmacol., 425
- Herbrener, 2000, Anhedonia in schizophrenia: Longitudinal Analyses, American Psychiatric Association Conference. Conference Proceeding
- Jasinski, 1989, Human abuse liability assesment by measurement of subjective and physiological effects. Testing for abuse liability of drugs in humans, NIDA Res. Monogr., 93, 73
- Segal, 1996, Biobehavioral effects of psychoactive drugs (Chapter 16). In Neurobehavioural toxicology and addiction, 451
- Tremblay, 2000, Response to d-amphetamine is altered in Major Depressive Disorder (MDD), Clin. Pharmacol. Ther., 67, 130
- Tremblay, 2000, Probing the Brain Reward System in Major Depressive Disorder: Altered response to d-amphetamine
Cited by
Sorted by citations
The Neural Correlates of Anhedonia in Major Depressive Disorder
Keedwell, P. A., Andrew, C., Williams, S. C. R., Brammer, M. J., & Phillips, M. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.019 · Cited by 650
Carver, C. S., Johnson, S. L., & Joormann, J. (2008) · Psychological Bulletin · doi:10.1037/a0013740 · Cited by 510
Lack of Ventral Striatal Response to Positive Stimuli in Depressed Versus Normal Subjects
Epstein, J., Pan, H., Kocsis, J. H., Yang, Y., Butler, T., Chusid, J., Hochberg, H., Murrough, J., Strohmayer, E., Stern, E., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1784 · Cited by 464
Pryce, C. R., Rüedi‐Bettschen, D., Dettling, A. C., Weston, A. A., Russig, H., Ferger, B., & Feldon, J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.011 · Cited by 430
Zhang, W.-N., Chang, S.-H., Guo, L.-Y., Zhang, K.-L., & Wang, J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.039 · Cited by 355
Tremblay, L. K., Naranjo, C. A., Graham, S. J., Herrmann, N., Mayberg, H. S., Hevenor, S., & Busto, U. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1228 · Cited by 340
Self-citationNeural Evidence for Enhanced Error Detection in Major Depressive Disorder
Chiu, P. H., & Deldin, P. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.608 · Cited by 310
Neurobiological mechanisms of anhedonia
Gorwood, P. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/pgorwood · Cited by 285
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 296
Familial, Social, and Individual Factors Contributing to Risk for Adolescent Substance Use
Whitesell, M., Bachand, A. M., Peel, J. L., & Brown, M. (2013) · Journal of Addiction · doi:10.1155/2013/579310 · Cited by 276
Bolaños, C. A., Barrot, M., Berton, O., Wallace-Black, D., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00570-5 · Cited by 266
Millan, M. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.038 · Cited by 260
Distinctions between bipolar and unipolar depression
Cuellar, A. K., Johnson, S. L., & Winters, R. W. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.12.002 · Cited by 259
Ng, T. H., Alloy, L. B., & Smith, D. V. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0644-x · Cited by 244
Reinforcement learning in depression: a review of computational research
Chen, C., Takahashi, T., Nakagawa, S., Inoue, T., & Kusumi, I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.005 · Cited by 233
Rademacher, D. J., Meier, S. E., Shi, L., Vanessa Ho, W.-S., Jarrahian, A., & Hillard, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.012 · Cited by 233
Tremblay, L. K., Naranjo, C. A., Cardenas, L., Herrmann, N., & Busto, U. E. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.409 · Cited by 229
Self-citationThe antidepressant effect of running is associated with increased hippocampal cell proliferation
Bjørnebekk, A., Mathé, A. A., & Brené, S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005122 · Cited by 236
Why Don't You Try Harder? An Investigation of Effort Production in Major Depression
Cléry-Melin, M.-L., Schmidt, L., Lafargue, G., Baup, N., Fossati, P., & Pessiglione, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023178 · Cited by 191
Kaviani, H., Gray, J. A., Checkley, S. A., Raven, P., Wilson, G. D., & Kumari, V. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.04.007 · Cited by 194
The Environmental Reward Observation Scale (EROS): Development, validity, and reliability
Armento, M. E. A., & Hopko, D. R. (2007) · Behavior Therapy · doi:10.1016/j.beth.2006.05.003 · Cited by 190
The Psychopathology and Treatment of Bipolar Disorder
Miklowitz, D. J., & Johnson, S. L. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095332 · Cited by 191
Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission
Dalla, C., Antoniou, K., Kokras, N., Drossopoulou, G., Papathanasiou, G., Bekris, S., Daskas, S., & Papadopoulou‐Daifoti, Z. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.020 · Cited by 180
Beute, F., & de Kort, Y. A. W. (2018) · Health & Place · doi:10.1016/j.healthplace.2017.11.005 · Cited by 159
Dopamine D2-Like Receptors and the Antidepressant Response
Gershon, A. A., Vishne, T. H., & Grunhaus, L. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.031 · Cited by 166
Sexual Partner Preference Requires a Functional Aromatase (Cyp19) Gene in Male Mice
Bakker, J., Honda, S., Harada, N., & Balthazart, J. (2002) · Hormones and Behavior · doi:10.1006/hbeh.2002.1805 · Cited by 157
Kujawa, A., Proudfit, G. H., & Klein, D. N. (2014) · Journal of Abnormal Psychology · doi:10.1037/a0036285 · Cited by 157
Zangen, A., & Hyodo, K. (2002) · NeuroReport · doi:10.1097/00001756-200212200-00005 · Cited by 145
Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor
Skolnick, P., Popik, P., Janowsky, A. J., Beer, B., & LIPPA, A. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01310-4 · Cited by 146
Behavioral Alterations in Reward System Function
GUYER, A. E., KAUFMAN, J., HODGDON, H. B., MASTEN, C. L., JAZBEC, S., PINE, D. S., & ERNST, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000227882.50404.11 · Cited by 137
Brain Systems Underlying Susceptibility to Helplessness and Depression
Shumake, J., & Gonzalez-Lima, F. (2003) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582303259057 · Cited by 139
Pearson, R. M., Lightman, S. L., & Evans, J. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.09.013 · Cited by 136
Molteni, R., Calabrese, F., Bedogni, F., Tongiorgi, E., Fumagalli, F., Racagni, G., & Andrea Riva, M. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005766 · Cited by 132
Pearson, R. M., Melotti, R., Heron, J., Joinson, C., Stein, A., Ramchandani, P. G., & Evans, J. (2012) · Infant Behavior and Development · doi:10.1016/j.infbeh.2012.07.020 · Cited by 128
Takeuchi, H., Taki, Y., Asano, K., Asano, M., Sassa, Y., Yokota, S., Kotozaki, Y., Nouchi, R., & Kawashima, R. (2018) · Human Brain Mapping · doi:10.1002/hbm.24286 · Cited by 149
Neural mechanisms of reinforcement learning in unmedicated patients with major depressive disorder
Rothkirch, M., Tonn, J., Köhler, S., & Sterzer, P. (2017) · Brain · doi:10.1093/brain/awx025 · Cited by 124
Depressive symptoms in early pregnancy disrupt attentional processing of infant emotion
Pearson, R. M., Cooper, R. M., Penton‐Voak, I. S., Lightman, S. L., & Evans, J. (2009) · Psychological Medicine · doi:10.1017/s0033291709990961 · Cited by 128
The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression
McLean, A., Rubinsztein, J. S., Robbins, T. W., & Sahakian, B. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1586-8 · Cited by 125
Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression?
Argyropoulos, S. V., & Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113494104 · Cited by 127
Cognitive, Behavioral, and Affective Responses to Reward: Links with Hypomanic Symptoms
Johnson, S. L., Ruggero, C. J., & Carver, C. S. (2005) · Journal of Social and Clinical Psychology · doi:10.1521/jscp.2005.24.6.894 · Cited by 126
Evaluation of reward processes in an animal model of depression
Slattery, D. A., Markou, A., & Cryan, J. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0630-x · Cited by 125
The neural circuitry of reward and its relevance to psychiatric disorders
Chau, D. T., Roth, R. M., & Green, A. I. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0026-8 · Cited by 123
Reward‐aversion circuitry in analgesia and pain: Implications for psychiatric disorders
Borsook, D., Becerra, L. R., Carlezon, W. A., Shaw, M. E., Renshaw, P. F., Elman, I., & Levine, J. D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.12.005 · Cited by 124
Shipton, E. A., & Shipton, E. E. (2015) · Pain Research and Treatment · doi:10.1155/2015/904967 · Cited by 128
Martins, D., Rademacher, L., Gabay, A. S., Taylor, R., Richey, J. A., Smith, D. V., Goerlich, K. S., Nawijn, L., Cremers, H. R., Wilson, R., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.034 · Cited by 119
Vitamin D and Autism Spectrum Disorder: A Literature Review
Mazahery, H., Camargo, C., Conlon, C., Beck, K., Kruger, M., & Von Hurst, P. (2016) · Nutrients · doi:10.3390/nu8040236 · Cited by 110
Structural and functional models of depression: from sub‐types to substrates
Malhi, G. S., Parker, G. B., & Greenwood, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00475.x · Cited by 115
Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder
Wang, Z., Wang, X., Liu, J., Chen, J., Liu, X., Nie, G., Jorgenson, K., Sohn, K. C., Huang, R., Liu, M., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.014 · Cited by 108
Cognitive control under contingencies in anxious and depressed adolescents: an antisaccade task
Jazbec, S., McClure, E., Hardin, M., Pine, D. S., & Ernst, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.010 · Cited by 106
Short- and Long-Term Functional Consequences of Fluoxetine Exposure During Adolescence in Male Rats
Iñiguez, S. D., Warren, B. L., & Bolaños‐Guzmán, C. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.033 · Cited by 111
Preclinical and Clinical Pharmacology of DOV 216,303, a “Triple” Reuptake Inhibitor
Skolnick, P., Krieter, P. A., Tizzano, J. P., Basile, A. S., Popik, P., Czobor, P., & LIPPA, A. S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00123.x · Cited by 107
Burkhouse, K. L., Kujawa, A., Kennedy, A. E., Shankman, S. A., Langenecker, S. A., Phan, K. L., & Klumpp, H. (2016) · Depression and Anxiety · doi:10.1002/da.22482 · Cited by 108
Iñiguez, S. D., Vialou, V., Warren, B. L., Cao, J.-L., Alcantara, L. F., Davis, L. C., Manojlovic, Z., Neve, R. L., Russo, S. J., Han, M.-H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0951-10.2010 · Cited by 103
Alwarappan, S., Liu, G., & Li, C. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.06.003 · Cited by 103
The empirical status of melancholia: Implications for psychology
Leventhal, A. M., & Rehm, L. P. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.09.001 · Cited by 112
Carvalho, J. P., Gawrysiak, M. J., Hellmuth, J. C., McNulty, J. K., Magidson, J. F., Lejuez, C. W., & Hopko, D. R. (2011) · Behavior Therapy · doi:10.1016/j.beth.2010.05.004 · Cited by 97
Roiser, J. P., Blackwell, A. D., Cools, R., Clark, L., Rubinsztein, D. C., Robbins, T. W., & Sahakian, B. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301055 · Cited by 98
Rawal, A., Collishaw, S., Thapar, A., & Rice, F. J. (2012) · Psychological Medicine · doi:10.1017/s0033291712001158 · Cited by 101
Emerging drugs for major depressive disorder
Connolly, K. R., & Thase, M. E. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.660146 · Cited by 94
Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
Emiliano, A. B., Cruz, T., Pannoni, V., & Fudge, J. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301206 · Cited by 94
Oestrogen‐deficient female aromatase knockout (ArKO) mice exhibit ‘depressive‐like’ symptomatology
Dalla, C., Antoniou, K., Papadopoulou‐Daifoti, Z., Balthazart, J., & Bakker, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03443.x · Cited by 93
Nichkova, M. I., Wynveen, P. M., Marc, D. T., Huisman, H. G., & Kellermann, G. H. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12248 · Cited by 92
Guiard, B. P., Mansari, M. E., & Blier, P. (2009) · Current Drug Targets · doi:10.2174/138945009789735156 · Cited by 99
Deficits in sustaining reward responses in subsyndromal and syndromal major depression
Liu, W.-H., Chan, R. C. K., Wang, L.-Z., Huang, J., Cheung, E. F. C., Gong, Q.-Y., & Gollan, J. K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.018 · Cited by 85
Dalby, R. B., Chakravarty, M. M., Ahdidan, J., Sørensen, L. U., Frandsen, J. R., Jónsdóttir, K. Ý., Tehrani, E., Rosenberg, R., Østergaard, L., & Videbech, P. (2009) · Psychological Medicine · doi:10.1017/s0033291709991656 · Cited by 85
Hwang, J. W., Xin, S., Ou, Y., Zhang, W. Y., Liang, Y., Chen, J., Yang, X., Chen, X. Y., Guo, T., Yang, X., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.005 · Cited by 85
The Ups and Downs of Modelling Mood Disorders in Rodents
Slattery, D. A., & Cryan, J. F. (2014) · ILAR Journal · doi:10.1093/ilar/ilu026 · Cited by 92
Sánchez-Santed, F., Cañadas, F., Flores, P., López-Grancha, M., & Cardona, D. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2003.10.008 · Cited by 84
Emotional dysfunction in Parkinson's disease.
Blonder, L. X., & Slevin, J. T. (2011) · PubMed Central · doi:10.3233/ben-2011-0329 · Cited by 86
Retinoid-Mediated Regulation of Mood: Possible Cellular Mechanisms
O’Reilly, K. C., Bailey, S., & Lane, M. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0706-mr-158 · Cited by 84
Emotional Dysfunction in Parkinson’s Disease
Blonder, L. X., & Slevin, J. T. (2011) · Behavioural Neurology · doi:10.1155/2011/143857 · Cited by 91
Zhang, D., Shen, J., Bi, R., Zhang, Y., Zhou, F., Feng, C., & Gu, R. (2020) · Psychological Medicine · doi:10.1017/s0033291720003967 · Cited by 82
Basso, A. M., Gallagher, K. B., Bratcher, N. A., Brioni, J. D., Moreland, R. B., Hsieh, G. C., Drescher, K. U., Fox, G. B., Decker, M. W., & Rueter, L. E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300677 · Cited by 79
Friedman, A., Frankel, M., Flaumenhaft, Y., Merenlender, A., Pinhasov, A., Feder, Y., Taler, M., Gil‐Ad, I., Abeles, M., & Yadid, G. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.177 · Cited by 78
Rezayof, A., Zarrindast, M., Sahraei, H., & Haeri-Rohani, A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00989-9 · Cited by 78
Promising Neuroimaging Biomarkers in Depression
Lai, C. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.07.25.2 · Cited by 75
Gender-specific effects of social housing on chronic stress-induced limbic FOS expression
Westenbroek, C., den Boer, J. A., & Horst, G. J. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00367-1 · Cited by 73
Krupıć, D., & Corr, P. J. (2017) · Psihologijske teme · doi:10.31820/pt.26.1.2 · Cited by 73
Rincón‐Cortés, M., & Grace, A. A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112367 · Cited by 72
Chopra, K., & Arora, V. K. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.855720 · Cited by 77
Tsai, S., Gau, Y. A., Hong, C., Liou, Y., Yu, Y. W. ‐., & Chen, T. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.017 · Cited by 72
Career Effects of Mental Health
Biasi, B., Dahl, M. S., & Moser, P. (2015) · National Bureau of Economic Research · doi:10.2139/ssrn.2544251 · Cited by 80
Zhao, B., Li, Z., Wang, Y., Ma, X., Wang, X., Wang, X., Liu, J., Huang, Y., Zhang, J., Li, L., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.005 · Cited by 71
Lai, C. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110234 · Cited by 71
Severity of gambling is associated with severity of depressive symptoms in pathological gamblers
Thomsen, K. R., Callesen, M. B., Linnet, J., Kringelbach, M. L., & Møller, A. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305e7a · Cited by 73
Relationship between DHA status at birth and child problem behaviour at 7 years of age
Krabbendam, L., Bakker, E. C., Hornstra, G., & van Os, J. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.09.004 · Cited by 72
Rezayof, A., Hosseini, S.-S., & Zarrindast, M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.030 · Cited by 68
Smartphone-based ecological momentary assessment reveals mental health benefits of birdlife
Hammoud, R., Tognin, S., Burgess, L. C., Bergou, N., Smythe, M., Gibbons, J., Davidson, N., Afifi, A., Bakolis, I., & Mechelli, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-20207-6 · Cited by 72
Prefrontal/accumbal catecholamine system processes high motivational salience
Puglisi‐Allegra, S., & Ventura, R. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00031 · Cited by 71
Lai, C. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318205a670 · Cited by 69
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders
Drago, A., & Serretti, A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30864 · Cited by 66
Carpenter, K. M., Brooks, A. C., Vosburg, S. K., & Nunes, E. V. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.015 · Cited by 64
The role of lead and cadmium in psychiatry
Orisakwe, O. E. (2014) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.139283 · Cited by 63
Bolaños, C. A., Perrotti, L. I., Edwards, S., Eisch, A. J., Barrot, M., Olson, V. G., Russell, D. S., Neve, R. L., & Nestler, E. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07569.2003 · Cited by 62
Neurophysiological differences in reward processing in anhedonics
Padrão, G., Mallorquí, A., Cucurell, D., Marco‐Pallarés, J., & Rodríguez‐Fornells, A. (2012) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-012-0119-5 · Cited by 69
The neurological basis of occupation
Gutman, S. A., & Schindler, V. P. (2007) · Occupational Therapy International · doi:10.1002/oti.225 · Cited by 61
Kokane, S. S., Armant, R. J., Bolaños‐Guzmán, C. A., & Perrotti, L. I. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112548 · Cited by 63
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
Amiaz, R., Fostick, L., Gershon, A. A., & Zohar, J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.006 · Cited by 61
Lai, C., & Wu, Y. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.022 · Cited by 60
Metadata
- Authors
- Naranjo, C. A., Tremblay, L. K., & Busto, U. E.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Naranjo, Claudio A.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 25
- Issue
- 4
- Pages
- 781-823
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2040295810
- Cited by
- 245
- References
- 271
- Citations by year
- 2025: 7 · 2024: 5 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 9 · 2018: 13 · 2017: 11 · 2016: 10 · 2015: 8 · 2014: 7 · 2013: 13 · 2012: 13
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- brain reward system, major depressive disorder, anhedonia, dopamine, mesocorticolimbic dopamine system, amphetamine challenge, hydromorphone, motivation, depression pathophysiology
- MeSH terms
- Amphetamine, Central Nervous System Stimulants, Animals, Brain, Brain Chemistry, Depressive Disorder, Humans, Reward
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review